PMI Accused of Manipulating Science for Profit: Guardian Report

PMI by 2FIRSTS.ai
Jul.02.2024
PMI Accused of Manipulating Science for Profit: Guardian Report
PMI accused of manipulating science for profit through research funding and advocacy efforts, targeting non-smokers with IQOS products.

According to a recent report by The Guardian, Philip Morris International (PMI) has been accused of "manipulating science for profit" through funding scientific research and advocacy work.

 

Activists say that leaked documents from PMI and its Japanese subsidiary also reveal their plans to target politicians, doctors, and the marketing strategy for the 2020 Tokyo Olympics in order to attract non-smokers to use their heated tobacco product, IQOS.

 

Japan is the initial market for IQOS, with the tobacco industry watchdog organization Stopping Tobacco Organisations and Products (Stop) stating concerns that PMI may apply this strategy to other markets.

 

A research report from the Tobacco Control Research Group at the University of Bath in the UK has revealed that Philip Morris Japan (PMJ) funded a smoking cessation study at Kyoto University through a third-party research institution.

 

Despite a spokesperson for PMI stating that its participation was announced at the 2021 Greek Science Conference, researchers claim that they have been unable to find any public records of PMI's involvement.

 

The PMJ pays approximately £20,000 per month to FTI-Innovations, a life science consulting company managed by a professor from the University of Tokyo, to promote PMI's science and products in academic activities. An internal email from a PMJ employee stated that they were instructed to "keep it confidential.

 

This paper, published in the Journal of Nicotine and Tobacco Research, is based on 24 leaked company documents from the years 2012 to 2020.

 

Researchers say that

 

These activities are similar to known strategies that influence the research, publication, and dissemination of science, while concealing scientific activity.

 

One of the authors of the paper, Dr. Sophie Braznell, stated that

 

The manipulation of science for profit has harmed all of us, especially policymakers and consumers trying to make potentially life-changing decisions. This has hindered and undermined public health policies, while encouraging the widespread use of harmful products.

 

Brazier argued that the leaked documents undermined the PMI's claim of conducting "transparent science" and called for reforms in the funding and governance of tobacco research "to protect science from corporate interests.

 

In a separate report based on leaked documents, Stop claimed that PMJ appeared to be lobbying for permission to use IQOS in smoke-free areas for their company marketing activities.

 

Stop indicates that organizations including medical and hospitality groups, as well as the Japan Fire and Disaster Management Agency, have been targeted as supporters, "if supported, it could give the impression that IQOS is widely accepted."

 

The focus on the Tokyo Olympics reflects a known industry strategy in sports events to promote addictive and harmful tobacco products by associating them with health, misleading consumers, and targeting children and young people. STOP Director Jorge Alday stated that the investigation results contradict PMI's claim that IQOS is only intended for adult smokers.

 

The intention of PMI with IQOS seems to far exceed what they have claimed. This finding adds weight to doubts about PMI's intentions and product statements.

 

Alarming is the implication of a wider deceptive strategy pattern, which may lay the foundation for a new chapter in the tobacco epidemic.

 

A spokesperson for PMI stated that

 

This is yet another false story from an organization that is more focused on criticizing our company rather than helping reduce the harms of smoking. Like any highly regulated multinational company, PMI regularly shares our positions on issues that impact our consumers, company, and communities. This engagement is not only completely legal and appropriate, but also crucial for inclusive policy making that leads to better policy outcomes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Virginia Attorney General Backs Vape Enforcement Act Limiting Sales to FDA-Authorized or Pending Products
Virginia Attorney General Backs Vape Enforcement Act Limiting Sales to FDA-Authorized or Pending Products
Virginia Attorney General Jay Jones is backing new vape enforcement legislation that he said would do more than warn people about the dangers of vaping. The proposal would tighten rules on which products can be sold and increase enforcement aimed at keeping vapes out of the hands of young people.
Mar.24 by 2FIRSTS.ai
Russia’s Volgograd fines retailer 300,000 rubles for unlabelled nicotine products, orders confiscation and destruction
Russia’s Volgograd fines retailer 300,000 rubles for unlabelled nicotine products, orders confiscation and destruction
Volgograd, Russia say a retailer was caught selling unlabelled nicotine products, including electronic nicotine delivery devices flagged in the national “Honest Sign” tracking system as already withdrawn from circulation. A local court fined the entrepreneur 300,000 rubles and ordered 41 confiscated items to be destroyed, with the decision now in effect.
Feb.05 by 2FIRSTS.ai
Special Report|From Nicotine Pouches to Jelly? A China Tobacco Patent Explores Dual-Release NRT
Special Report|From Nicotine Pouches to Jelly? A China Tobacco Patent Explores Dual-Release NRT
A patent published on February 24, 2026, by China Tobacco Hubei Industrial Co., Ltd. introduces a “nicotine jelly” product designed to combine rapid and sustained nicotine delivery. By integrating both free and microencapsulated nicotine, the product aims to address key limitations of traditional nicotine replacement therapy (NRT), while also raising new regulatory and product classification questions.
Innovation
Mar.18
FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA schedules online roundtable to gather small manufacturers’ input on ENDS PMTA requirements
FDA announced it will convene a Feb. 10, 2026 roundtable with small tobacco product manufacturers to gather feedback on PMTA submissions for ENDS products. The discussion will be viewable online, and a public docket is open for comments through March 12, 2026.
Feb.10 by 2FIRSTS.ai
Spain’s Nicotine Pouch Sales Reached 5 Million Cans in 2025, Industry Says 2026 Could Hit 8 Million
Spain’s Nicotine Pouch Sales Reached 5 Million Cans in 2025, Industry Says 2026 Could Hit 8 Million
Spain’s Nicotine Pouch Association said nicotine pouch sales in Spain reached 5 million cans of 20 units in 2025 and are expected to rise 60% to 8 million in 2026. The group said there are currently 20 to 30 brands on the Spanish market and called for regulation proportionate to product risk. It also opposed a proposal to reduce nicotine content to 0.99 mg per pouch, saying it would amount to a de facto ban on the category.
Mar.19 by 2FIRSTS.ai
USITC Launches Section 337 Probe Into Disposable and Closed-System ENDS, Involving 16 Companies
USITC Launches Section 337 Probe Into Disposable and Closed-System ENDS, Involving 16 Companies
The U.S. International Trade Commission (USITC) voted to institute a Section 337 investigation into certain disposable and other closed-system electronic nicotine delivery systems (ENDS) devices and components thereof (Inv. No. 337-TA-1486). The investigation stems from a complaint filed on January 13, 2026 by R.J. Reynolds entities based in Winston-Salem, North Carolina, supplemented on February 3, 2026.
Mar.05 by 2FIRSTS.ai